Antimicrobial agent resistance in mycobacteria: molecular genetic insights

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Clinical Microbiology Reviews

• Publication date

  1995-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/CMR.8.4.496PMID 8665467PMCID PMC172873
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A new synthetic compound with antituberculous activity in mice: ethambutol (dextro-2,2'-(ethylenediimino)-di-l-butanol).

  2015cited by this paper
• Therapeutic effect of a new antibacterial substance ofloxacin (DL8280) on pulmonary tuberculosis.

  2015cited by this paper
• Primary structure of Escherichia coli RNA polymerase nucleotide substitution in the β subunit gene of the rifampicin resistant rpoB255 mutant

  2004cited by this paper
• Mutation to rifampicin resistance at the beginning of the RNA polymerase β subunit gene in Escherichia coli

  2004cited by this paper
• RNA polymerase rifampicin resistance mutations in Escherichia coli: Sequence changes and dominance

  2004cited by this paper
• Tuberculosis: Pathogenesis, Protection and Control

  1996cited by this paper
• Characterization of the catalase-peroxidase gene (katG) and inhA locus in isoniazid-resistant and -susceptible strains of Mycobacterium tuberculosis by automated DNA sequencing: restricted array of mutations associated with drug resistance.

  1996cited by this paper
• Molecular mechanisms of multiple drug resistance in clinical isolates of Mycobacterium tuberculosis.

  1995influential reference
• [Mycobacterium avium complex].

  1995cited by this paper
• Temporal trends and transmission patterns during the emergence of multidrug-resistant tuberculosis in New York City: a molecular epidemiologic assessment.

  1995cited by this paper
• Rapid identification of a point mutation of the Mycobacterium tuberculosis catalase-peroxidase (katG) gene associated with isoniazid resistance.

  1995cited by this paper
• Rapid Mycobacterium species assignment and unambiguous identification of mutations associated with antimicrobial resistance in Mycobacterium tuberculosis by automated DNA sequencing.

  1995influential reference
• Mutation position and type of substitution in the beta-subunit of the RNA polymerase influence in-vitro activity of rifamycins in rifampicin-resistant Mycobacterium tuberculosis.

  1995cited by this paper
• Genotypic detection of Mycobacterium tuberculosis rifampin resistance: comparison of single-strand conformation polymorphism and dideoxy fingerprinting

  1995cited by this paper
• Drug-resistant strains of Mycobacterium tuberculosis exhibit a range of virulence for mice

  1995cited by this paper
• Effect of inhA and katG on isoniazid resistance and virulence of Mycobacterium bovis

  1995cited by this paper
• Crystal structure and function of the isoniazid target of Mycobacterium tuberculosis

  1995cited by this paper
• Direct genotypic detection of Mycobacterium tuberculosis rifampin resistance in clinical specimens by using single-tube heminested PCR

  1995influential reference
• Missense mutations in the catalase‐peroxidase gene, katG, are associated with isoniazid resistance in Mycobacterium tuberculosis

  1995cited by this paper
• Emergence of fluoroquinolone-resistant tuberculosis in New York City.

  1995cited by this paper
• Protein EnvM is the NADH-dependent enoyl-ACP reductase (FabI) of Escherichia coli.

  1994cited by this paper
• Selection of a gyrA mutant of Mycobacterium tuberculosis resistant to fluoroquinolones during treatment with ofloxacin.

  1994cited by this paper
• Is Mycobacterium tuberculosis 15,000 years old?

  1994cited by this paper
• Cloning and sequence analysis of the rpsL and rpsG genes of Mycobacterium smegmatis and characterization of mutations causing resistance to streptomycin

  1994influential reference
• inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis.

  1994influential reference
• Expanded tuberculosis surveillance and tuberculosis morbidity--United States, 1993.

  1994cited by this paper
• Mutations in the catalase-peroxidase gene from isoniazid-resistant Mycobacterium tuberculosis isolates.

  1994cited by this paper
• Drug-resistant tuberculosis: laboratory issues. World Health Organization recommendations.

  1994cited by this paper
• The rpoB gene of Mycobacterium tuberculosis

  1994cited by this paper
• Selection of a gyrA mutant of Mycobacterium tuberculosis resistant to fluoroquinolones during treatment with ofloxacin.

  1994cited by this paper
• Trends in the susceptibility of tuberculosis in New York City, 1987-1991. New York City Area Tuberculosis Working Group.

  1994cited by this paper
• Characterization of rifampin-resistance in pathogenic mycobacteria

  1994cited by this paper
• Characterization by automated DNA sequencing of mutations in the gene (rpoB) encoding the RNA polymerase beta subunit in rifampin-resistant Mycobacterium tuberculosis strains from New York City and Texas

  1994influential reference
• Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations

  1994cited by this paper
• Characterization of mutations in Mycobacterium smegmatis involved in resistance to fluoroquinolones

  1994cited by this paper
• Streptomycin resistance in mycobacteria

  1994influential reference
• Effects of peroxides on susceptibilities of Escherichia coli and Mycobacterium smegmatis to isoniazid

  1994cited by this paper
• Tuberculosis Pathogenesis, Protection, and Control

  1994cited by this paper
• Disease due to the Mycobacterium avium complex in patients with AIDS: epidemiology and clinical syndrome.

  1994cited by this paper
• Implications of multidrug resistance for the future of short-course chemotherapy of tuberculosis: a molecular study

  1994influential reference
• Evaluation of the rpoB gene in rifampicin-susceptible and -resistant Mycobacterium avium and Mycobacterium intracellulare.

  1994cited by this paper
• Nationwide survey of drug-resistant tuberculosis in the United States.

  1994cited by this paper
• Erratum: Selection of a gyrA mutant of Mycobacterium tuberculosis resistant to fluoroquinolones during treatment with ofloxacin (Journal of Infectious Diseases (1994) 170 (479-83))

  1994cited by this paper
• Tetracycline resistance determinants in Mycobacterium and Streptomyces species

  1994cited by this paper
• Genetic alterations in streptomycin-resistant Mycobacterium tuberculosis: mapping of mutations conferring resistance

  1994cited by this paper
• Identification of Mycobacterium tuberculosis DNA in a pre-Columbian Peruvian mummy.

  1994cited by this paper
• Detection of a genetic locus encoding resistance to rifampin in mycobacterial cultures and in clinical specimens.

  1994cited by this paper
• Identification of mutations in 23S rRNA gene of clarithromycin-resistant Mycobacterium intracellulare

  1994cited by this paper
• Catalase-peroxidase gene sequences in isoniazid-sensitive and -resistant strains of Mycobacterium tuberculosis from New York City.

  1993cited by this paper
• Identification of two point mutations and a one base deletion in exon 19 of the dystrophin gene by heteroduplex formation.

  1993cited by this paper
• Current status of mycobacterial testing in clinical laboratories. Results of a questionnaire completed by participants in the College of American Pathologists Mycobacteriology E survey.

  1993cited by this paper
• Recommendations on prophylaxis and therapy for disseminated Mycobacterium avium complex for adults and adolescents infected with human immunodeficiency virus. U.S. Public Health Service Task Force on Prophylaxis and Therapy for Mycobacterium avium Complex.

  1993cited by this paper
• Current practices in mycobacteriology: results of a survey of state public health laboratories

  1993cited by this paper
• PITFALLS IN THE CARE OF PATIENTS WITH TUBERCULOSIS: COMMON ERRORS AND THEIR ASSOCIATION WITH THE ACQUISITION OF DRUG RESISTANCE

  1993cited by this paper
• Current status of mycobacterial testing in clinical laboratories. Results of a questionnaire completed by participants in the College of American Pathologists Mycobacteriology E survey.

  1993cited by this paper
• The Mycobacterium avium complex

  1993cited by this paper
• Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis.

  1993cited by this paper
• Disease Control Priorities in Developing Countries

  1993cited by this paper
• Molecular basis of streptomycin resistance in Mycobacterium tuberculosis: alterations of the ribosomal protein S12 gene and point mutations within a functional 16S ribosomal RNA pseudoknot

  1993cited by this paper
• Characterization of the katG gene encoding a catalase-peroxidase required for the isoniazid susceptibility of Mycobacterium tuberculosis

  1993cited by this paper
• Quinolone antimicrobial agents

  1993cited by this paper
• A ribosomal gene mutation in streptomycin-resistant Mycobacterium tuberculosis isolates.

  1993influential reference
• Diagnostic Mycobacteriology: Current Challenges and Technologies

  1993cited by this paper
• Crystal structure of a complex between electron transfer partners, cytochrome c peroxidase and cytochrome c.

  1993cited by this paper
• Susceptibilities of oxyR regulon mutants of Escherichia coli and Salmonella typhimurium to isoniazid

  1993cited by this paper
• Tuberculosis symposium: emerging problems and promise.

  1993cited by this paper
• The rpsL gene and streptomycin resistance in single and multiple drug‐resistant strains of Mycobacterium tuberculosis

  1993cited by this paper
• Ethambutol inhibition of glucose metabolism in mycobacteria: a possible target of the drug

  1993cited by this paper
• Transformation with katG restores isoniazid‐sensitivity in Mycobacterium tuberculosis isolates resistant to a range of drug concentrations

  1993cited by this paper
• Direct, automated detection of rifampin-resistant Mycobacterium tuberculosis by polymerase chain reaction and single-strand conformation polymorphism analysis

  1993cited by this paper
• Molecular mechanisms of isoniazid: a drug at the front line of tuberculosis control.

  1993cited by this paper
• Nucleotide sequence of the first cosmid from the Mycobacterium leprae genome project: structure and function of the Rif‐Str regions

  1993cited by this paper
• History of tuberculosis

  1993cited by this paper
• Molecular basis of rifampin resistance in Mycobacterium leprae

  1993influential reference
• Synthesis and biological activity of 3'-hydroxy-5'-aminobenzoxazinorifamycin derivatives.

  1993cited by this paper
• Two controlled trials of rifabutin prophylaxis against Mycobacterium avium complex infection in AIDS.

  1993influential reference
• Mycobacterium smegmatis RNA polymerase: DNA supercoiling, action of rifampicin and mechanism of rifampicin resistance

  1993cited by this paper
• The emergence of drug-resistant tuberculosis in New York City.

  1993cited by this paper
• Tuberculosis: Commentary on a Reemergent Killer

  1992cited by this paper
• Treatment of Mycobacterium avium complex bacteremia in AIDS with a four-drug oral regimen. Rifampin, ethambutol, clofazimine, and ciprofloxacin. The California Collaborative Treatment Group.

  1992cited by this paper
• The catalase—peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis

  1992cited by this paper
• Sequences of the envM gene and of two mutated alleles in Escherichia coli.

  1992cited by this paper
• Detecting single base substitutions as heteroduplex polymorphisms.

  1992cited by this paper
• Clinical Presentation and Outcome of Patients with HIV Infection and Tuberculosis Caused by Multiple-Drug-resistant Bacilli

  1992cited by this paper
• Clarithromycin minimal inhibitory and bactericidal concentrations against Mycobacterium avium.

  1992cited by this paper
• Effectiveness of the macrolide clarithromycin in the treatment ofMycobacterium avium complex infection in HIV-infected patients

  1992cited by this paper
• A controlled study of rifabutin and an uncontrolled study of ofloxacin in the retreatment of patients with pulmonary tuberculosis resistant to isoniazid, streptomycin and rifampicin. Hong Kong Chest Service/British Medical Research Council.

  1992cited by this paper
• A microtitre format point mutation assay: Application to the detection of drug resistance in human immunodeficiency virus type‐1 infected patients treated with zidovudine

  1992cited by this paper
• The catalase-peroxidase of Mycobacterium intracellulare: nucleotide sequence analysis and expression in Escherichia coli.

  1992cited by this paper
• Activities of clarithromycin against eight slowly growing species of nontuberculous mycobacteria, determined by using a broth microdilution MIC system

  1992cited by this paper
• Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organisms

  1992cited by this paper
• Combined chemotherapy including rifabutin for rifampicin and isoniazid resistant pulmonary tuberculosis. G.E.T.I.M. (Group for the Study and Treatment of Resistant Mycobacterial Infection).

  1992cited by this paper
• Isoniazid inhibition of mycolic acid synthesis by cell extracts of sensitive and resistant strains of Mycobacterium aurum

  1991cited by this paper
• Activity of clarithromycin against Mycobacterium avium infection in patients with the acquired immune deficiency syndrome. A controlled clinical trial.

  1991cited by this paper
• Drug-resistant tuberculosis.

  1991cited by this paper
• The global tuberculosis situation and the new control strategy of the World Health Organization.

  1991cited by this paper
• Mutations in the 915 region of Escherichia coli 16S ribosomal RNA reduce the binding of streptomycin to the ribosome.

  1991cited by this paper
• Solid-phase gene assembly

  1991cited by this paper
• Mycobacterium avium complex infection in the acquired immunodeficiency syndrome.

  1991cited by this paper
• Drug Susceptibility in the Chemotherapy of Mycobacterial Infections

  1991cited by this paper

• Comparative evaluation of molecular technologies for the identification of prevalent non-tuberculous mycobacteria in pulmonary infections: a systematic review and meta-analysis

  2026cites this paper
• The microevolutionary trajectory of endemic multidrug-resistant tuberculosis strains in Portugal toward increased drug resistance levels and its clinical significance

  2026influential citation
• Direct detection from sputum for drug-resistant Mycobacterium tuberculosis using a CRISPR-Cas14a-based approach

  2025cites this paper
• Diverse impacts of different rpoB mutations on the anti-tuberculosis efficacy of capreomycin

  2025cites this paper
• Whole-genome sequencing for analyzing the transmission characteristics of drug-resistant Mycobacterium tuberculosis in Ganzhou, China

  2025cites this paper
• Sentinel-Site-Based Surveillance of Mycobacterium tuberculosis Drug Resistance and Epidemiology in Sichuan, China

  2025cites this paper
• VAMP-Net: An Interpretable Multi-Path Framework of Genomic Permutation-Invariant Set Attention and Quality-Aware 1D-CNN for MTB Drug Resistance

  2025cites this paper
• Strategic diagnosis- Unraveling Tuberculosis- A comprehensive approach.

  2024cites this paper
• Drug-resistance characteristics, genetic diversity, and transmission dynamics of multidrug-resistant or rifampicin-resistant Mycobacterium tuberculosis from 2019 to 2021 in Sichuan, China

  2024cites this paper
• Genome sequences of Mycobacterium sp. Elmwood and accompanying phage, isolated from a public swimming pool in Nebraska

  2024cites this paper
• Legionella pneumophila exploits the endo-lysosomal network for phagosome biogenesis by co-opting SUMOylated Rab7

  2024cites this paper
• Strain-specific Growth Parameters are Important to Accurately Model Bacterial Growth on Baby Spinach in Simulation Models.

  2024cites this paper
• Molecular Characteristics and Prevalence of Rifampin Resistance in Staphylococcus aureus Isolates from Patients with Bacteremia in South Korea

  2023cites this paper
• Differences in Physiological Performance and Gut Microbiota between Deep-Sea and Coastal Aquaculture of Thachinotus Ovatus: A Metagenomic Approach

  2023cites this paper
• Selective Pressure by Rifampicin Modulates Mutation Rates and Evolutionary Trajectories of Mycobacterial Genomes

  2023cites this paper
• Integrating Molecular Diagnostics and GIS Mapping: A Multidisciplinary Approach to Understanding Tuberculosis Disease Dynamics in South Africa Using Xpert MTB/RIF

  2023cites this paper
• Study of structurally diverse currently used and recently developed antimycobacterial drugs.

  2023cites this paper
• Manipulation of Bacterial ROS Production Leads to Self-escalating DNA Damage and Resistance-resistant Lethality for Intracellular Mycobacteria

  2023cites this paper
• Identifying targets to prevent aminoglycoside ototoxicity.

  2022cites this paper
• A multidrug efflux protein in Mycobacterium tuberculosis; tap as a potential drug target for drug repurposing

  2022cites this paper
• First Detection of Mycobacterium tuberculosis Clinical Isolates Harboring I491F Borderline Resistance rpoB Mutation in Myanmar

  2022cites this paper
• Metabolic genes on conjugative plasmids are highly prevalent in Escherichia coli and can protect against antibiotic treatment

  2022cites this paper
• Evaluation of whole-genome sequence to predict drug resistance of nine anti-tuberculosis drugs and characterize resistance genes in clinical rifampicin-resistant Mycobacterium tuberculosis isolates from Ningbo, China

  2022cites this paper
• Issues in Mycobacterium tuberculosis Complex Drug Susceptibility Testing: Rifampin

  2022cites this paper
• Use of Whole-Genome Sequencing to Predict Mycobacterium tuberculosis Complex Drug Resistance from Early Positive Liquid Cultures

  2022influential citation
• Pharmacophore modeling, docking and the integrated use of a ligand- and structure-based virtual screening approach for novel DNA gyrase inhibitors: synthetic and biological evaluation studies

  2021cites this paper
• Bioinformatic analysis of multi-drug resistant class 1 integron-coded protein of Citrobacter freundii

  2021cites this paper
• Drug resistance, fitness and compensatory mutations in Mycobacterium tuberculosis.

  2021cites this paper
• Rifampin-resistance-associated mutations in the rifampin-resistance-determining region of the rpoB gene of Mycobacterium tuberculosis clinical isolates in Shanghai, PR China.

  2021cites this paper
• Fluoroquinolones: a review on anti-tubercular activity

  2021cites this paper
• Disputed rpoB Mutations in Mycobacterium tuberculosis and Tuberculosis Treatment Outcomes

  2021cites this paper
• Molecular Analysis of Streptomycin Resistance Genes in Clinical Strains of Mycobacterium tuberculosis and Biocomputational Analysis of the MtGidB L101F Variant

  2021cites this paper
• Label‐Free Near‐Infrared Plasmonic Sensing Technique for DNA Detection at Ultralow Concentrations

  2020cites this paper
• Differential expression of resistant and efflux pump genes in MDR-TB isolates.

  2020cites this paper
• Exploration of Ion Channels in Mycobacterium tuberculosis: Implication on Drug Discovery and Potent Drug Targets Against Tuberculosis

  2020cites this paper
• Targeting the multidrug efflux pump; Tap protein to reduce survival of Mycobacterium tuberculosis

  2020cites this paper
• Effect of Photodynamic Therapy Enhanced by Methylene Blue on Drug-resistant Mycobacterium smegmatis

  2020cites this paper
• Detection of tuberculous meningitis by various microbiological modalities at a tertiary care hospital in north India

  2020cites this paper
• Monomeric NADH-Oxidizing Methylenetetrahydrofolate Reductases from Mycobacterium smegmatis Lack Flavin Coenzyme

  2020cites this paper
• What are the origins of growing microbial resistance? Both Lamarck and Darwin were right

  2020cites this paper
• What are the origins of growing microbial resistance? Both Lamarck and Darwin were right

  2020cites this paper
• The geographical profile of rpoB mutations observed in Mycobacterium tuberculosis clinical isolates from two DOTS clinics

  2020cites this paper
• Prediction of rifampicin resistance beyond the RRDR using structure-based machine learning approaches

  2020cites this paper
• Use of whole-genome sequencing to predict Mycobacterium tuberculosis drug resistance in Shanghai, China.

  2020cites this paper
• Drug-resistant Mycobacterium tuberculosis and its genotypes isolated from an outbreak in western Thailand.

  2020cites this paper
• Probe A shown in the GeneXpert MTB/RIF assay during the detection of Mycobacterium intracellular infections.

  2020cites this paper
• Development of New Therapeutics to Meet the Current Challenge of Drug Resistant Tuberculosis.

  2020cites this paper
• Identification of Genetic Features for Attenuation of Two Salmonella Enteritidis Vaccine Strains and Differentiation of These From Wildtype Isolates Using Whole Genome Sequencing

  2019cites this paper
• Molecular Basis of Drug Resistance in Mycobacteria

  2019cites this paper
• Other Pathogens

  2019cites this paper
• Second-line drug susceptibilities of multidrug- and rifampicin-resistant Mycobacterium tuberculosis isolates in Delhi

  2019influential citation
• The Challenge of Drug-Resistant Tuberculosis: An Update

  2019cites this paper
• Chemistry for a Clean and Healthy Planet

  2019influential citation
• Issues in Mycobacterium tuberculosis Complex ( MTBC ) Drug Susceptibility Testing : Rifampin ( RIF ) INFECTIOUS DISEASES APRIL 2019

  2019cites this paper
• Molecular Evidence of Drug-Resistant Tuberculosis in the Balimo Region of Papua New Guinea

  2019cites this paper
• Automatic Identification of Individual rpoB Gene Mutations Responsible for Rifampin Resistance in Mycobacterium tuberculosis by Use of Melting Temperature Signatures Generated by the Xpert MTB/RIF Ultra Assay

  2019cites this paper
• Synthesis and antitubercular activity of triazole-linked 1,4-benzoquinone derivatives

  2019cites this paper
• Performance of Xpert MTB/RIF Assay for Childhood Pulmonary Tuberculosis With Real World Evidence in China

  2019cites this paper
• REFERENCIAS BIBLIOGRÁFICAS

  2018cites this paper
• Molecular Analysis of katG Encoding Catalase-Peroxidase from Clinical Isolate of Isoniazid-Resistant Mycobacterium tuberculosis

  2018cites this paper
• Validation of Novel Mycobacterium tuberculosis Isoniazid Resistance Mutations Not Detectable by Common Molecular Tests

  2018cites this paper
• Evolution of drug resistance in Mycobacterium tuberculosis: a review on the molecular determinants of resistance and implications for personalized care

  2018cites this paper
• The occurrence and frequency of genomic mutations that mediate Isoniazid and Rifampicin resistance in Mycobacterium tuberculosis isolates from untreated pulmonary Tuberculosis cases in urban Blantyre, Malawi

  2018cites this paper
• Resistance to anti leprosy drugs in multi-bacillary leprosy: A cross sectional study from a tertiary care centre in eastern Uttar Pradesh, India

  2018cites this paper
• Ethionamide and Clarithromycin in Mycobacterium tuberculosis Pak Armed Forces Med J 2010; 60(2): 173-6 173 IN VITRO EFFICACY OF ETHIONAMIDE AND CLARITHROMYCIN IN MYCOBACTERIUM TUBERCULOSIS ISOLATES

  2018cites this paper
• Review on Tuberculosis: Trends in the Discovery of New and Efficient Chemotherapeutic Agents

  2018cites this paper
• Performance of GenoType® MTBDRplus assay in the diagnosis of drug-resistant tuberculosis in Tangier, Morocco.

  2018cites this paper
• Enhancement of Gold Nanoparticle Coupling with a 2D Plasmonic Crystal at High Incidence Angles.

  2018cites this paper
• Characterization of Ofloxacin Interaction with Mutated (A91V) Quinolone Resistance Determining Region of DNA Gyrase in Mycobacterium Leprae through Computational Simulation

  2018cites this paper
• Alphanumerical Visual Display Made of DNA Logic Gates for Drug Susceptibility Testing of Pathogens

  2018cites this paper
• Emergence and selection of isoniazid and rifampin resistance in tuberculosis granulomas

  2018cites this paper
• Identification of rpoB, gyrA and embB Gene Mutations in Mycobacterium Tuberculosis Isolates from Retreatment Tuberculosis Patients in Nepal

  2018cites this paper
• Species-Specific Interactions of Arr with RplK Mediate Stringent Response in Bacteria

  2018cites this paper
• Fabrication of sensors for the sensitive electrochemical detection of anti-tuberculosis drugs

  2018cites this paper
• Novel compounds targeting InhA for TB therapy

  2018cites this paper
• IDENTIFICATION OF AND GENE MUTATIONS IN ISOLATES FROM RETREATMENT TUBERCULOSIS PATIENTS IN NEPAL

  2018cites this paper
• Characterization of Mycobacterium tuberculosis isolates with discordant rifampicin susceptibility test results

  2018cites this paper
• Interested in publishing with us ? Contact book

  2018cites this paper
• Leyre and Knapp, Charles W. and Gálvez, Antonio and Abriouel, Hikmate (2016) Biocide tolerance, phenotypic and molecular response of Lactic Acid Bacteria isolated from naturally-fermented Aloreña table olives

  2018cites this paper
• Design, synthesis and biological evaluation of antimicrobial agents: bromopyrrole-cinnamaldehyde hybrids.

  2018cites this paper
• [Drug resistance in Mycobacterium tuberculosis: contribution of constituent and acquired mechanisms].

  2018cites this paper
• Sequence Analysis of Rifampicin Resistance Determining Region (RRDR) of Mycobacterium tuberculosis

  2018cites this paper
• Lekooporność w gruźlicy - aspekty mikrobiologiczne i kliniczne.

  2017cites this paper
• Molecular Characterization of Mycobacterium bovis and its Significance: Role for Control of Zoonotic Tuberculosis in Africa

  2017cites this paper
• The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis.

  2017cites this paper
• Rifampicin Resistance and Multidrug-Resistant Tuberculosis Detection Using Xpert MTB/RIF in Wuhan, China: A Retrospective Study

  2017cites this paper
• Challenges beyond elimination in leprosy

  2017cites this paper
• The Whys and Wherefores of Antibiotic Resistance.

  2017cites this paper
• Simultaneous detections of genetic fragment and single nucleotide mutation with a three-tiered output for tuberculosis diagnosis.

  2017cites this paper
• Antimicrobial resistance in Mycobacterium tuberculosis: mechanistic and evolutionary perspectives

  2017cites this paper
• Drug development against tuberculosis: Past, present and future.

  2017cites this paper
• Molecular screening of multidrug-resistance tuberculosis by a designated public health laboratory in Taiwan

  2017cites this paper
• Analysis of isoniazid and rifampicin resistance in Mycobacterium tuberculosis isolates in Morocco using GenoType® MTBDRplus assay.

  2017cites this paper
• New Insights in to the Intrinsic and Acquired Drug Resistance Mechanisms in Mycobacteria

  2017cites this paper
• In vitro and in vivo fitness costs associated with Mycobacterium tuberculosis RpoB mutation H526D.

  2017cites this paper
• Are WHO approved nucleic acid amplification tests causing large-scale “false identification” of rifampicin-resistant tuberculosis?: Programmatic experience from south india

  2017cites this paper
• PROCESS FOR DETECTION OF MULTIDRUG RESISTANTTUBERCULOSS USING REAL-TIME PCRAND HIGH RESOLUTION MELTANALYSIS REFERENCE TO RELATED APPLICATION

  2017cites this paper
• A comprehensive characterization of PncA polymorphisms that confer resistance to pyrazinamide

  2017cites this paper
• Ribosomal mutations promote the evolution of antibiotic resistance in a multidrug environment

  2017influential citation
• Molecular characterisation of rifampicin-resistant Mycobacterium tuberculosis strains from Malawi

  2017cites this paper